Sintx Technologies (SINT) to Release Quarterly Earnings on Tuesday

Sintx Technologies (NASDAQ:SINT) is anticipated to post its Q2 2026 results before the market opens on Tuesday, August 11th. Analysts expect the company to post earnings of ($0.69) per share and revenue of $0.46 million for the quarter. Parties may visit the the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Tuesday, August 11, 2026 at 4:30 PM ET.

Sintx Technologies (NASDAQ:SINT) last released its quarterly earnings results on Friday, May 15th. The company reported ($0.70) EPS for the quarter, missing analysts’ consensus estimates of ($0.66) by ($0.04). The business had revenue of $0.38 million during the quarter, compared to analysts’ expectations of $0.30 million. Sintx Technologies had a negative net margin of 1,058.60% and a negative return on equity of 366.49%. On average, analysts expect Sintx Technologies to post $-2 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

Sintx Technologies Price Performance

NASDAQ SINT traded down $0.09 during trading on Tuesday, hitting $1.68. The company’s stock had a trading volume of 12,880 shares, compared to its average volume of 40,076. The company has a market cap of $7.26 million, a PE ratio of -0.33 and a beta of 0.62. The business’s 50 day simple moving average is $1.89 and its 200-day simple moving average is $2.46. Sintx Technologies has a fifty-two week low of $1.40 and a fifty-two week high of $6.78.

Hedge Funds Weigh In On Sintx Technologies

A hedge fund recently raised its position in Sintx Technologies stock. Geode Capital Management LLC raised its position in Sintx Technologies, Inc. (NASDAQ:SINT) by 53.4% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 26,624 shares of the company’s stock after buying an additional 9,265 shares during the period. Geode Capital Management LLC owned about 0.72% of Sintx Technologies worth $103,000 at the end of the most recent quarter. Institutional investors and hedge funds own 18.38% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the stock. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Sintx Technologies in a research report on Friday, July 17th. HC Wainwright reaffirmed a “buy” rating and issued a $10.00 price target on shares of Sintx Technologies in a report on Wednesday, May 20th. Maxim Group reiterated a “buy” rating and set a $6.00 price objective on shares of Sintx Technologies in a research note on Thursday, June 4th. Finally, Ascendiant Capital Markets dropped their price objective on shares of Sintx Technologies from $16.00 to $12.00 and set a “buy” rating on the stock in a report on Wednesday, April 8th. Three investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat, Sintx Technologies currently has an average rating of “Moderate Buy” and a consensus price target of $9.33.

Sintx Technologies Company Profile

Sintx Technologies, Inc (NASDAQ: SINT) is a medical materials company specializing in the development and manufacture of silicon nitride-based biomaterials for surgical and implantable medical devices. Its proprietary silicon nitride ceramic combines mechanical strength, biocompatibility and intrinsic antimicrobial properties, positioning it as an alternative to traditional metal and polymer implant materials. Sintx’s primary focus is on applications in spinal fusion, trauma fixation and dental implantology, where device performance and long-term biological response are critical.

The company’s core product offerings include silicon nitride powders for advanced implant fabrication and finished implantable components designed for interbody spinal fusion cages, spinal fixation hardware and trauma plates and screws.